Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Classe

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
Cancers|October 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of SurgeryGilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 9, 2023
Multicentric development and evaluation of <sup>18</sup>F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancerFrançois Lucia, Vincent Bourbonne, Clémence Pleyers, et al.
Gynecologic Oncology|May 30, 2020
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trialFabrice Narducci, Emilie Bogart, Thomas Hebert, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2016
Survival impact and predictive factors of axillary recurrence after sentinel biopsyGilles Houvenaeghel, Jean Marc Classe, Jean-Rémy Garbay, et al.
Bulletin Du Cancer|April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
BMC Cancer|January 12, 2019
Lymph node positivity in different early breast carcinoma phenotypes: a predictive modelGilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Breast (Edinburgh, Scotland)|August 2, 2016
Breast cancer in young women: Pathologic features and molecular phenotypeLaura Sabiani, Gilles Houvenaeghel, Mellie Heinemann, et al.
Cancers|October 16, 2024
Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of SurgeryGilles Houvenaeghel, Jean-Marc Classe, Marie-Pierre Chauvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 9, 2023
Multicentric development and evaluation of <sup>18</sup>F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancerFrançois Lucia, Vincent Bourbonne, Clémence Pleyers, et al.
Gynecologic Oncology|May 30, 2020
Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trialFabrice Narducci, Emilie Bogart, Thomas Hebert, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective studyGilles Houvenaeghel, Alexandre de Nonneville, Monique Cohen, et al.
Breast Cancer Research and Treatment|February 14, 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefitAlexandre de Nonneville, Camille Jauffret, Anthony Gonçalves, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2016
Survival impact and predictive factors of axillary recurrence after sentinel biopsyGilles Houvenaeghel, Jean Marc Classe, Jean-Rémy Garbay, et al.
Bulletin Du Cancer|April 12, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
BMC Cancer|January 12, 2019
Lymph node positivity in different early breast carcinoma phenotypes: a predictive modelGilles Houvenaeghel, Eric Lambaudie, Jean-Marc Classe, et al.
Bulletin Du Cancer|January 31, 2026
[French recommendations for clinical practice, Nice-Saint-Paul de Vence 2024-2025: Management of high-grade ovarian epithelial cancer]Frédéric Selle, Manuel Rodrigues, Benoît You, et al.
Pageof 11